Severe asthma and COVID-19: lessons from the first wave

References

• Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, Wu Y, Zhang L, Yu Z, Fang M, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. doi:https://doi.org/10.1016/S2213-2600(20)30079-5.
   PubMed Web of Science ®Google Scholar
• Patrucco F, Villa E, Foci V, Benfante A, Bellocchia M, Solidoro P. Severe asthma at COVID-19 time: what's new on biologic therapies. Minerva Med. 2020. doi:https://doi.org/10.23736/S0026-4806.20.06727-0.
   Google Scholar
• Wu Y-H, Lai AC-Y, Chi P-Y, Thio CL-P, Chen W-Y, Tsai C-H, Lee YL, Lukacs NW, Chang Y-J. Pulmonary IL-33 orchestrates innate immune cells to mediate respiratory syncytial virus-evoked airway hyperreactivity and eosinophilia. Allergy. 2020;75(4):818–830. doi:https://doi.org/10.1111/all.14091.
   PubMed Web of Science ®Google Scholar
• Gavala ML, Bashir H, Gern JE. Virus/allergen interactions in asthma. Curr Allergy Asthma Rep. 2013;13(3):298–307. doi:https://doi.org/10.1007/s11882-013-0344-1.
   PubMed Web of Science ®Google Scholar
• Zheng X-Y, Xu Y-J, Guan W-J, Lin L-F. Regional, age and respiratory-secretion-specific prevalence of respiratory viruses associated with asthma exacerbation: a literature review. Arch Virol. 2018;163(4):845–853. doi:https://doi.org/10.1007/s00705-017-3700-y.
   PubMed Web of Science ®Google Scholar
• Van Bever HP, Chng SY, Goh DY. Childhood severe acute respiratory syndrome, coronavirus infections and asthma. Pediatr Allergy Immunol. 2004;15(3):206–209. doi:https://doi.org/10.1111/j.1399-3038.2004.00137.x.
   PubMed Web of Science ®Google Scholar
• Zhang J-j, Dong X, Cao Y-y, Yuan Y-d, Yang Y-b, Yan Y-q, Akdis CA, Gao Y-d. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:https://doi.org/10.1111/all.14238.
   PubMed Web of Science ®Google Scholar
• Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:https://doi.org/10.1016/j.jaci.2020.04.006.
   Web of Science ®Google Scholar
• Garg S, Kim L, Whitaker M, O'Halloran A, Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, et al. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–464. doi:https://doi.org/10.15585/mmwr.mm6915e3.
   PubMed Web of Science ®Google Scholar
• Huang K, Yang T, Xu J, Yang L, Zhao J, Zhang X, Bai C, Kang J, Ran P, Shen H, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407–418. doi:https://doi.org/10.1016/S0140-6736(19)31147-X.
   PubMed Web of Science ®Google Scholar
• Hanon S, Brusselle G, Deschampheleire M, Louis R, Michils A, Peché R, Pilette C, Rummens P, Schuermans D, Simonis H, et al. COVID-19 and biologics in severe asthma: data from the Belgian Severe Asthma Registry. Eur Respir J. 2020;56(6):2002857. doi:https://doi.org/10.1183/13993003.02857-2020.
   PubMed Web of Science ®Google Scholar
• Heffler E, Detoraki A, Contoli M, Papi A, Paoletti G, Malipiero G, Brussino L, Crimi C, Morrone D, Padovani M, et al. COVID-19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments. Allergy. 2020. doi:https://doi.org/10.1111/all.14532.
   Web of Science ®Google Scholar
• Matucci A, Caminati M, Vivarelli E, Vianello A, Micheletto C, Menzella F, Crisafulli E, Passalacqua G, Bagnasco D, Lombardi C, et al. COVID-19 in severe asthmatic patients during ongoing treatment with biologicals targeting type 2 inflammation: results from a multicenter Italian survey. Allergy. 2020. doi:https://doi.org/10.1111/all.14516.
   Google Scholar
• Shaker MS, Oppenheimer J, Grayson M, Stukus D, Hartog N, Hsieh EWY, Rider N, Dutmer CM, Vander Leek TK, Kim H, et al. COVID-19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477–1488.e5. doi:https://doi.org/10.1016/j.jaip.2020.03.012.
   Web of Science ®Google Scholar
• Morais-Almeida M, Aguiar R, Martin B, Ansotegui IJ, Ebisawa M, Arruda LK, Caminati M, Canonica GW, Carr T, Chupp G, et al. COVID-19, asthma, and biologic therapies: what we need to know. World Allergy Organ J. 2020;13(5):100126. doi:https://doi.org/10.1016/j.waojou.2020.100126.
   PubMed Web of Science ®Google Scholar
• Licari A, Votto M, Brambilla I, Castagnoli R, Piccotti E, Olcese R, Tosca MA, Ciprandi G, Marseglia GL. Allergy and asthma in children and adolescents during the COVID outbreak: what we know and how we could prevent allergy and asthma flares? Allergy. 2020;75(9):2402–2405. doi:https://doi.org/10.1111/all.14369.
   PubMed Web of Science ®Google Scholar
• Daccord C, Touilloux B, Von Garnier C. Asthma and COPD management during the COVID-19 pandemic. Rev Med Suisse. 2020;16(692):933–938.
   PubMedGoogle Scholar
• Pennington E. Asthma increases risk of severity of COVID-19. Cleve Clin J Med. 2020. doi:https://doi.org/10.3949/ccjm.87a.ccc002.
   Google Scholar
• Patruno C, Stingeni L, Fabbrocini G, Hansel K, Napolitano M. Dupilumab and COVID-19: what should we expect? Dermatol Ther. 2020;33(4):e13502. doi:https://doi.org/10.1111/dth.13502.
   Google Scholar
• Levin M, Ansotegui IJ, Bernstein J, Chang Y-S, Chikhladze M, Ebisawa M, Fiocchi A, Heffler E, Martin B, Morais-Almeida M, et al. Acute asthma management during SARS-CoV2-pandemic 2020. World Allergy Organ J. 2020;13(5):100125. doi:https://doi.org/10.1016/j.waojou.2020.100125.
   PubMed Web of Science ®Google Scholar
• Principe S, Benfante A, Calzetta L, Rogliani P, Scichilone N. Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics. World Allergy Organ J. 2019;12(11):100081. doi:https://doi.org/10.1016/j.waojou.2019.100081.
   PubMed Web of Science ®Google Scholar
• Benfante A, Principe S, Battaglia S, Scichilone N. Are biological drugs effective and safe in older severe asthmatics? Expert Opin Drug Saf. 2019;18(5):369–380. doi:https://doi.org/10.1080/14740338.2019.1607838.
   PubMed Web of Science ®Google Scholar
• COVID-19: GINA answers to frequently asked questions on asthma management. 2020 Mar 25 [accessed 2020 Nov 5]. https://ginasthma.org/covid-19-gina-answers-to-frequently-asked-questions-on-asthma-management/.
   Google Scholar
• Advice for healthcare professionals treating people with asthma (adults) in relation to COVID-19. British Thoracic Society. 2020 Apr 07 [Accessed 2020 Nov 5]. https://brit-thoracic.org.uk/document-library/quality-improvement/covid-19/bts-advice-for-healthcare-professionals-treating-patients-with-asthma/.
   Google Scholar
• COVID-19 rapid guideline: severe asthma NICE guideline [NG166]. 2020 Apr 03. [accessed 2020 Nov 5] https://www.nice.org.uk/guidance/ng166.
   Google Scholar
• Licskai C, Yang CL, Ducharme FM, Radhakrishnan D, Podgers D, Ramsey C, Samanta T, Côté A, Mahdavian M, Lougheed MD, et al. Key highlights from the Canadian Thoracic Society position statement on the optimization of asthma management during the coronavirus disease 2019 pandemic. Chest. 2020;158(4):1335–1337. doi:https://doi.org/10.1016/j.chest.2020.05.551.
   PubMed Web of Science ®Google Scholar
• RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, et al. Dexamethasone in hospitalized patients with covid-19 - preliminary report. N Engl J Med. 2020:NEJMoa2021436. doi:https://doi.org/10.1056/NEJMoa2021436.
   Web of Science ®Google Scholar
• Ong KY, Tan TL, Chan AKW, Tan KLL, Koh MS. Managing asthma in the COVID-19 pandemic and current recommendations from professional bodies: a review. J Asthma. 2020;1–8. doi:https://doi.org/10.1080/02770903.2020.1804578.
   Google Scholar